Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

The medications may help prevent further tissue damage after a heart attack (myocardial infarction), according to a new study ...

An eye-opening study from the VA Saint Louis Healthcare System shows what quitting weight-loss drugs can do to the heart.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...

A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...